(Q43766830)

26 November 2017

0 references

The treatment of cytomegalovirus in AIDS--more than meets the eye (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309391

11 September 2022

The Treatment of Cytomegalovirus in AIDS — More Than Meets the Eye (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM199201233260409

30 November 2023

0 references

0 references

M. S. Hirsch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1309391

11 September 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

26 November 2017

23 January 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1309391

full work available at URL

11 September 2022

http://www.nejm.org/doi/pdf/10.1056/NEJM199201233260409

1 reference

https://api.crossref.org/works/10.1056/NEJM199201233260409

The New England Journal of Medicine

30 November 2023

published in

1 reference

26 November 2017

volume

326

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

264-266

1 reference

Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate

26 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1056/NEJM199201233260409

Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

30 November 2023

2

1 reference

https://api.crossref.org/works/10.1056/NEJM199201233260409

A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS

30 November 2023

3

1 reference

https://api.crossref.org/works/10.1056/NEJM199201233260409

Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro

30 November 2023

4

1 reference

https://api.crossref.org/works/10.1056/NEJM199201233260409

In Vivo Additive Antiretroviral Effect of Combined Zidovudine and Foscarnet Therapy for Human Immunodeficiency Virus Infection (ACTG Protocol 053)

30 November 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM199201233260409

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

30 November 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM199201233260409

Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study

30 November 2023

8

1 reference

https://api.crossref.org/works/10.1056/NEJM199201233260409

Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus

30 November 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM199201233260409

Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro

30 November 2023

10

1 reference

https://api.crossref.org/works/10.1056/NEJM199201233260409

30 November 2023

Identifiers

1 reference

26 November 2017

1 reference